|
|
|
See related Byetta inj information
|
|
| Exenatide |
| Treatment of type 2 DM in combination w/ metformin, a sulfonylurea or a combination of metformin & sulphonylurea. |
| 5 mcg/dose bid SC. May increase dose to 10 mcg bid after 1 mth of therapy. |
|
View
Byetta overdosage
for action to be taken in the event of an overdose.
|
| Not for type 1 DM or diabetic ketoacidosis. Do not use in end-stage renal disease or severe renal impairment (<30 mL/min), severe GI disease. |
| This is not a substitute for insulin in insulin-requiring diabetes. Pregnancy & lactation. Childn. |
| Hypoglcemia, decreased appetite, headache, dizziness, nausea, vomiting, diarrhea, dyspepsia, abdominal pain, GERD, abdominal distention, hyperhidrosis, feeling jittery, asthenia.
View
ADR Monitoring Website |
| May increase hypoglycemia when used w/ a sulfonylurea. OC, antibiotics, warfarin.
View
more drug interactions with Byetta |
| | Category C: Either studies in animals have
revealed adverse effects on the foetus (teratogenic or embryocidal or
other) and there are no controlled studies in women or studies in women and
animals are not available. Drugs should be given only if the potential benefit
justifies the potential risk to the foetus.
|
|
|
For caution against possible variation of physical aspect of medicine...
click to view
|
|
View
Byetta storage
conditions for details to ensure optimal shelf-life.
|
|
View
Byetta description
for details of the chemical structure and excipients (inactive components).
|
|
View
Byetta mechanism of action
for pharmacodynamics and pharmacokinetics details.
|
| Antidiabetic Agents |
| A10BX04 -
Exenatide ;
Belongs to the class of other blood glucose lowering drugs excluding insulins. Used in the management of diabetes. |
| Rx |
|
|
|
|